Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Einstein Noah Restaurant Group, Inc. (BAGL): Are Hedge Funds Right About This Stock?

Page 1 of 2

Is Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL) undervalued? Investors who are in the know are betting on the stock. The number of bullish hedge fund bets advanced by 1 recently.

Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL)

In the 21st century investor’s toolkit, there are plenty of metrics shareholders can use to watch publicly traded companies. Some of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top investment managers can trounce the S&P 500 by a solid margin (see just how much).

Equally as beneficial, positive insider trading activity is a second way to break down the marketplace. There are plenty of motivations for an executive to cut shares of his or her company, but just one, very clear reason why they would initiate a purchase. Many empirical studies have demonstrated the impressive potential of this method if shareholders understand what to do (learn more here).

Now, it’s important to take a peek at the recent action surrounding Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL).

Hedge fund activity in Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL)

At the end of the fourth quarter, a total of 8 of the hedge funds we track were long in this stock, a change of 14% from the third quarter. With the smart money’s capital changing hands, there exists a few notable hedge fund managers who were boosting their stakes substantially.

When looking at the hedgies we track, Greenlight Capital, managed by David Einhorn, holds the biggest position in Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL). Greenlight Capital has a $131.1 million position in the stock, comprising 2.1% of its 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $2 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other hedgies with similar optimism include Chuck Royce’s Royce & Associates, Israel Englander’s Millennium Management and D. E. Shaw’s D E Shaw.

As industrywide interest jumped, some big names were leading the bulls’ herd. Millennium Management, managed by Israel Englander, established the most outsized position in Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL). Millennium Management had 0.7 million invested in the company at the end of the quarter. Joel Greenblatt’s Gotham Asset Management also initiated a $0.3 million position during the quarter.

What do corporate executives and insiders think about Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past 180 days. Over the latest six-month time frame, Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL) has experienced zero unique insiders buying, and 4 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL). These stocks are Nathan’s Famous, Inc. (NASDAQ:NATH), Ruth’s Hospitality Group, Inc. (NASDAQ:RUTH), Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG), Luby’s, Inc. (NYSE:LUB), and Jamba, Inc. (NASDAQ:JMBA). All of these stocks are in the restaurants industry and their market caps are closest to BAGL’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!